118 related articles for article (PubMed ID: 36424364)
1. Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections.
Abouelhassan Y; Fratoni AJ; Shepard AK; Nicolau DP; Asempa TE
J Antimicrob Chemother; 2022 Dec; 78(1):296-301. PubMed ID: 36424364
[TBL] [Abstract][Full Text] [Related]
2. Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis.
Gill CM; Fratoni AJ; Shepard AK; Kuti JL; Nicolau DP
J Antimicrob Chemother; 2022 Apr; 77(5):1372-1378. PubMed ID: 35194643
[TBL] [Abstract][Full Text] [Related]
3. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
[TBL] [Abstract][Full Text] [Related]
4. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.
Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
Lancet Microbe; 2024 Apr; 5(4):e355-e365. PubMed ID: 38432233
[TBL] [Abstract][Full Text] [Related]
5. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
[TBL] [Abstract][Full Text] [Related]
6. Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via
Stainton SM; Monogue ML; Baummer-Carr A; Shepard AK; Nugent JF; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109162
[TBL] [Abstract][Full Text] [Related]
7. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
[TBL] [Abstract][Full Text] [Related]
8. Tebipenem pivoxil hydrobromide-No PICC, no problem!
Sodhi V; Kronsberg KA; Clark M; Cho JC
Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment.
Patel G; Rodvold KA; Gupta VK; Bruss J; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
Antimicrob Agents Chemother; 2022 May; 66(5):e0240721. PubMed ID: 35420493
[TBL] [Abstract][Full Text] [Related]
10. Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding.
Fouad A; Quintiliani R; Nicolau DP; Asempa TE
J Antimicrob Chemother; 2022 Dec; 78(1):205-208. PubMed ID: 36374528
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
Ganesan H; Gupta VK; Safir MC; Bhavnani SM; Talley AK; Melnick D; Rubino CM
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0145122. PubMed ID: 37191505
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects.
Gupta VK; Patel G; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
Clin Transl Sci; 2022 Jul; 15(7):1654-1663. PubMed ID: 35411579
[TBL] [Abstract][Full Text] [Related]
13. Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
Wiskirchen DE; Shepard A; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2011 Sep; 55(9):4170-5. PubMed ID: 21709078
[TBL] [Abstract][Full Text] [Related]
14. Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects.
Gupta VK; Maier G; Eckburg P; Morelli L; Lei Y; Jain A; Manyak E; Melnick D
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0014521. PubMed ID: 33875429
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.
Monogue ML; Stainton SM; Baummer-Carr A; Shepard AK; Nugent JF; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893779
[TBL] [Abstract][Full Text] [Related]
16. Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
Sugita R
J Infect Chemother; 2013 Jun; 19(3):465-71. PubMed ID: 23393013
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, Urinary Excretion, and Pharmaco-Metabolomic Study of Tebipenem Pivoxil Granules After Single Escalating Oral Dose in Healthy Chinese Volunteers.
Li Z; Su M; Cheng W; Xia J; Liu S; Liu R; Sun S; Feng L; Zhu X; Zhang X; Tian X; Qu L
Front Pharmacol; 2021; 12():696165. PubMed ID: 34326771
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.
Majcher-Peszynska J; Sass M; Schipper S; Czaika V; Gussmann A; Lobmann R; Mundkowski RG; Luebbert C; Kujath P; Ruf BR; Koch H; Schareck W; Klar E; Drewelow B;
Eur J Clin Pharmacol; 2011 Feb; 67(2):135-42. PubMed ID: 20871984
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
McEntee L; Johnson A; Farrington N; Unsworth J; Dane A; Jain A; Cotroneo N; Critchley I; Melnick D; Parr T; Ambrose PG; Das S; Hope W
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109982
[TBL] [Abstract][Full Text] [Related]
20. Absorption, Metabolism, and Excretion of [
Gupta VK; Maier G; Gasink L; Ek A; Fudeman M; Srivastava P; Talley A
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0150922. PubMed ID: 36995239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
